STAT Plus subscribers, we want to know what you think.

The last time we polled you, the new tax law was wending its way through Congress, Tom Price still had a seat in the Trump cabinet, and PhRMA was launching its “Go Boldly” campaign on the heels of a hike in membership fees.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Let me just say that unless something is done regarding PBM’s there will not be
    one Independent pharmacy left in this country. If that were to happen . Shame on this government !!!!!!

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy